Login
$DRUG
$51.09 -$1.39 (2.65%) Close

Consolidated Statements of Financial Position

In millions of CAD, except per-share amounts
Q4 FY2025
As of Sep 30, 2025
Q4 FY2024
As of Sep 30, 2024
Q4 FY2023
As of Sep 30, 2023
Q4 FY2022
As of Sep 30, 2022
Current Assets
Cash and cash equivalents
Sales tax receivables
Other receivables
Interest receivables
Prepaids
Current assets
Non-Current Assets
Right-of-use asset
TOTAL ASSETS
Current Liabilities
Accounts payable and accrued liabilities
Lease liability – current portion
Current liabilities
Lease liability – non-current portion
TOTAL LIABILITIES
Shareholders’ equity
Share capital
Pre-funded warrants
Reserves
Deficit
TOTAL SHAREHOLDERS’ EQUITY
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support